Trial Profile
Clinical Trials Insight: 700012629
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2006
Price :
$35
*
At a glance
- Drugs HT 0712 (Primary)
- Indications Memory disorders
- Focus Therapeutic Use
- Sponsors Helicon Therapeutics; Inflazyme Pharmaceuticals
- 08 Mar 2006 New trial record.